Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31.

Saved in:
Bibliographic Details
Title: Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31.
Authors: Pogue-Geile, Katherine L.1, Kim, Chungyeul1, Jeong, Jong-Hyeon1, Tanaka, Noriko1, Bandos, Hanna1, Gavin, Patrick G.1, Fumagalli, Debora1, Goldstein, Lynn C.1, Sneige, Nour1, Burandt, Eike1, Taniyama, Yusuke1, Bohn, Olga L.1, Lee, Ahwon1, Kim, Seung-Il1, Reilly, Megan L.1, Remillard, Matthew Y.1, Blackmon, Nicole L.1, Kim, Seong-Rim1, Horne, Zachary D.1, Rastogi, Priya1
Source: JNCI: Journal of the National Cancer Institute. Dec2013, Vol. 105 Issue 23, p1782-1788. 7p.
Database: Academic Search Ultimate
Description
ISSN:00278874
DOI:10.1093/jnci/djt321